Case | 5 June 2025

Setterwalls has advised OssDsign in connection with directed share issue of approximately SEK 158 million

Responsive image

Setterwalls has advised OssDsign AB in connection with a directed share issue of approximately SEK 158 million to Swedish and international institutional investors.

OssDsign is a developer and global provider of next generation orthobiologics products. The company’s shares are listed on Nasdaq First North Growth Market.

Contact:

Olof Reinholdsson, Anna Barnekow, Olivia Krantz

Practice areas:

Equity Capital Markets, Life Sciences

  • This field is for validation purposes and should be left unchanged.

Vill du komma i kontakt med oss?

Fyll i formuläret samt vilket kontor du vill bli kontaktad av, så hör vi av oss inom kort.

Related news

Setterwalls has advised Sleep Cycle in connection with the proposed acquisition of Audiowell for approximately SEK 2.3 billion

Case | 12 October 2026

Setterwalls has advised Sleep Cycle in connection with the proposed acquisition of Audiowell for approximately...

Read more
Setterwalls has advised Integrum AB in connection with a private placement of approximately SEK 22.9 million

Case | 30 September 2026

Setterwalls has advised Integrum AB in connection with a private placement of approximately SEK 22.9 million

Read more
Setterwalls has advised Hexicon in connection with the extension of a cross-border loan facility with Nuveen

Case | 14 September 2026

Setterwalls has advised Hexicon in connection with the extension of a cross-border loan facility with Nuveen

Read more
Load more